The PreEclampsia Postpartum Prevention Trial
- Sponsor
- Karolinska Institutet
- Study ID
- NCT07199283
- Status
- Recruiting
Conditions
- Cardiovascular Diseases
- Hypertension
- Obesity
- Overweight
- Postpartum Period
- Preeclampsia
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Bundle Intervention — OTHERBundle intervention
Study Details
The goal of this clinical trial is to learn if a postpartum bundle intervention can improve cardiometabolic health and lifestyle-related factors in women who have had preeclampsia during their first pregnancy. The main questions it aims to answer are: * Does the 9-month intervention reduce systolic and diastolic blood pressure? * Does the intervention promote postpartum weight loss? * Does the intervention affect weight and blood pressure depending on early pregnancy BMI? Researchers will compare the bundle intervention to standard care to see if the intervention improves cardiometabolic health and lifestyle outcomes. All participants will attend clinical visits for outcome assessments. Participants in the intervention group will: * Receive online targeted screening and group meetings with study personnel * Use the trial-specific PEPP app to access self-monitoring tools for blood pressure and weight, lifestyle modification, and health education * Follow the intervention in two phases: starting after inclusion (≈8 weeks postpartum) with a Light phase (baseline-3 months) and progressing to an Intensive phase (3-9 months)
Key Dates
- First listed
- Sep 30, 2025
- Start date
- Apr 20, 2026
- Status verified
- Apr 2026
- Primary completion
- Apr 30, 2028
- Completion
- Apr 30, 2028
Study Design
- Enrollment
- 356 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- No Intervention: Standard CareStandard care
- Experimental: Bundle InterventionBundle Intervention
Primary Outcome Measure
Change in systolic (sBP) blood pressure (mmHg) [ Time Frame: From baseline to end of study at 9 months follow-up ]
Central Contacts
- Kari Johansson, PhD+46851776278
- Anna Sandström, PhD, MD
Find similar trials
Related Studies
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Physical and Behavioral Traits of Overweight and Obese AdultsRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss TreatmentPHASE2 · Recruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Phoenix, Arizona
- Cardiovascular BiorepositoryEnrolling By Invitation · Kenneth S. Campbell · Lexington, Kentucky